Marksans Pharma share price
MARKSANS on NSE · data as of 16 Oct 2026
Marksans Pharma closed at ₹311.00 on 16 Oct 2026 (+1.02% on the day). It is 11.4% below its 52-week high of ₹350.95 (24 Sept 2026) and 100.7% above its 52-week low of ₹155.00 (30 Mar 2026). The stock has outperformed the Nifty 50 over the past year (+71.3% vs -8.5%). It is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 36 (neutral zone).
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | MARKSANS | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +0.6% | +2.8% | −2.2 pts |
| 1 month | −1.7% | −0.3% | −1.4 pts |
| 3 months | +16.4% | −4.9% | +21.3 pts |
| 6 months | +72.6% | −4.3% | +76.9 pts |
| 1 year | +71.3% | −8.5% | +79.8 pts |
Trend and activity
- 50-day average: ₹320.89 (price below)
- 200-day average: ₹234.52 (price above)
- RSI (14 days): 36
- Turnover on 16 Oct 2026: ₹23.8 cr (0.4x the 20-day average volume)
New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Marksans Pharma?
The 52-week high of Marksans Pharma (MARKSANS) is ₹350.95, reached on 24 Sept 2026. The 52-week low is ₹155.00, on 30 Mar 2026 (NSE, as of 16 Oct 2026).
How has Marksans Pharma performed in the last year?
Over the last year the share price has moved +71.3%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.
Is Marksans Pharma in an uptrend?
As of 16 Oct 2026, Marksans Pharma is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 36 (neutral zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists